Angiotensin Receptor Blocking Blood Pressure May Fight CoVid19

24 de mar. de 2020 · 58s
Angiotensin Receptor Blocking Blood Pressure May Fight CoVid19
Descripción

  Vidcast:  https://youtu.be/AMGmbjdWo-o   The CoVid19 virus uses the angiotensin converting enzyme 2 or ACE2 as a binding site to human cells in the lungs, heart, and kidneys.  The angiotensin receptor blockers...

mostra más
  Vidcast:  https://youtu.be/AMGmbjdWo-o   The CoVid19 virus uses the angiotensin converting enzyme 2 or ACE2 as a binding site to human cells in the lungs, heart, and kidneys.  The angiotensin receptor blockers (ARBs) used to lower blood pressure increase ACE2 levels and may be able to diminish the damage the virus creates in vital organs.   Clinicians from China and India observe that the ARB drugs losartan and telmisartan bind strongest to the angiotensin receptors and would be most effective against CoVid19.  Since these drugs are already FDA-approved, drug trials using them for treating CoVid19 may be launched.   If you are on an ARB, stay on it as such studies unfold but don’t switch to it yet!   https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21656   https://www.bmj.com/content/368/bmj.m406/rr-2   #covid19 #coronavirus #angiotensin #arb
mostra menos
Información
Autor Howard G. Smith MD
Página web -
Etiquetas

Parece que no tienes ningún episodio activo

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Actual

Portada del podcast

Parece que no tienes ningún episodio en cola

Echa un ojo al catálogo de Spreaker para descubrir nuevos contenidos.

Siguiente

Portada del episodio Portada del episodio

Cuánto silencio hay aquí...

¡Es hora de descubrir nuevos episodios!

Descubre
Tu librería
Busca